• Ownership

Joshua A. Kazam - Insider Trading & Ownership

Entity
Individual
Location
689 5 Th Avenue, 12 Th Floor, New York, NY
Summary
The estimated net worth of Joshua A. Kazam is at least $1.84M dollars as of June 26, 2024. Joshua A. Kazam is the Director of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $1.84M.
All Insider Reports
All Insider Reports

Ownership of Joshua A. Kazam

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. Director $1.84M Jun 5, 2024
KRON Kronos Bio, Inc. Director Jun 25, 2024
SCRM Screaming Eagle Acquisition Corp. Director Jan 5, 2022
LTCH Latch, Inc. Former Director Jun 4, 2021

Insider Transactions Reported by Joshua A. Kazam:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.